Hydrocodone Bitartrate
12 NDCs across 2 manufacturers|6 Generic,6 Brand
Hydrocodone Bitartrate is used to treat cough, obstructive lung diseases and postoperative pain, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Oct 25, 2013, and the first generic was approved Jan 21, 2020. FDA's Orange Book lists 12 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $22 million on Hydrocodone Bitartrate across 40,000 claims for 7,003 beneficiaries.
Hydrocodone Bitartrate is available as 12 NDCs from 2 manufacturers (6 generic, 6 brand), with NADAC prices from $6.36 to $62.10 per EA — the most expensive product costs about 9.8× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
12
6G / 6B
Manufacturers
2
competing in market
Price Spread
$6.36 – $62.10
per EA
7d Activity
avg -0.1% WoW · of 12 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Purdue Pharma LP manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Opioid Agonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing HYDROCODONE BITARTRATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
HYSINGLA ER 100 MG TABLET | $62.0951 per EA | — |
HYSINGLA ER 80 MG TABLET | $48.6550 per EA | — |
HYSINGLA ER 60 MG TABLET | $36.1746 per EA | -0.29% |
HYSINGLA ER 40 MG TABLET | $26.1614 per EA | -0.11% |
HYSINGLA ER 30 MG TABLET | $19.3650 per EA | -0.12% |
HYSINGLA ER 20 MG TABLET | $13.3073 per EA | +0.04% |
HYDROCODONE ER 50 MG CAPSULE | $8.7548 per EA | — |
HYDROCODONE ER 20 MG TABLET | $8.0192 per EA | — |
HYDROCODONE ER 15 MG CAPSULE | $7.9469 per EA | -0.19% |
HYDROCODONE ER 30 MG CAPSULE | $7.2115 per EA | — |
HYDROCODONE ER 20 MG CAPSULE | $6.8748 per EA | — |
HYDROCODONE ER 10 MG CAPSULE | $6.3579 per EA | — |
Frequently Asked Questions
What is Hydrocodone Bitartrate used to treat?
Hydrocodone Bitartrate is used to treat cough, obstructive lung diseases and postoperative pain, per the National Library of Medicine's MED-RT classification.
When did Hydrocodone Bitartrate become available as a generic?
FDA approved the first generic Hydrocodone Bitartrate (ANDA) on Jan 21, 2020. The Orange Book currently lists 12 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Hydrocodone Bitartrate?
In 2024, Medicare Part D spent $22 million on Hydrocodone Bitartrate across 40,000 claims for 7,003 beneficiaries.
How many Hydrocodone Bitartrate products are on the market?
The Hydrocodone Bitartrate drug market contains 12 NDCs from 2 manufacturers — 6 generic and 6 brand products.
What is the price range for Hydrocodone Bitartrate?
NADAC reference prices for Hydrocodone Bitartrate range from $6.3579 to $62.0951 per EA — the most expensive product costs about 9.8× the cheapest.
Is generic Hydrocodone Bitartrate cheaper than brand?
The average generic NADAC for Hydrocodone Bitartrate is $7.5275 per EA, versus $34.2931 for brand-labeled products — brand versions average about 4.6× the generic price.
Which manufacturers make Hydrocodone Bitartrate?
2 manufacturers list Hydrocodone Bitartrate in NADAC. Ranked by number of NDCs, the largest are Purdue Pharma LP (6), Alvogen Inc. (6).
How has the price of Hydrocodone Bitartrate changed recently?
Over the past 7 days, 1 Hydrocodone Bitartrate NDC rose and 4 fell, with a market-wide average change of -0.1%.